CAS 361442-04-8 Purity >99.0% (HPLC) API
Ruifu Chemical Supply Related Intermediates
CAS 361442-04-8
CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Litlhaloso tse tšoanang | BMS-477118;Onglyza;(1S,3S,5S) -2-[(2S)-2-Amino-2-(3-Hydroxy-1-Adamantyl)acetyl]-2-Azabicyclo[3.1.0]hexane-3-Carbonitrile;(1S,3S,5S) -2-[(2S)-2-Amino-2-(3-Hydroxytricyclo [3.3.1.13,7]dec-1-yl)acetyl] -2-Azabicyclo[3.1.0]hexane -3-Carbonitrile |
Nomoro ea CAS | 361442-04-8 |
Nomoro ea KAtse | RF-PI1991 |
Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
Foromo ea limolek'hule | C18H25N3O2 |
Boima ba Molek'hule | 315.41 |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo e Tshweu |
Monko o monate | Sebopeho |
boitsebiso | A: IR B: HPLC Nako ea ho Boloka |
Mokhoa oa Bohloeki / Analysis | >99.0% (HPLC) |
Ho Hlakola ha Tharollo ea Metsi | Lintho tse Bonahalang, Tse se Nang Mebala, Ha ho na Litaba tse Emisitsoeng |
Sieve Analysis | 100% Feta 80 Mesh |
Melting Point | 202.0~212.0℃ |
Tahlehelo ka ho Omisa | <0.50% |
Molora oa Sulfate | <0.20% |
Phetoho e khethehileng | +174.0°~+186.0° |
Tšilafalo e le Mong | <0.50% |
Litšila ka Kakaretso | <1.00% |
Litšepe tse boima | <10ppm |
Arsenic (As) | <2.0ppm |
Ketapele (Pb) | <1.0ppm |
Cadmium (Cd) | <1.0ppm |
Metsoako e setseng | <100ppm |
Sebolaea Likokoanyana se Seng | E mpe |
Microbiology | |
Kakaretso ea Plate Count | <1000cfu/g |
Yeast & Mold | <100cfu/g |
E. Coli | E mpe |
S. Aureus | E mpe |
Salmonella | E mpe |
Shelf Life | Likhoeli tse 24 ho tloha ka Letsatsi la Tlhahiso haeba li bolokiloe hantle |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | API;Mofuta oa 2 oa lefu la tsoekere mellitus |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo
(BMS-477118) (CAS: 361442-04-8) ke inhibitor e matla, e khethang, e fetohang, ea tlhōlisano le e sebetsang ka molomo dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM).BMS-477118 e na le peotential bakeng sa mofuta oa 2 lefu la tsoekere mellitus.BMS-477118ke sethethefatsi sa lefu la tsoekere la mofuta oa 2 se ka susumetsang manyeme hore a hlahise insulin e ngata ka mor'a lijo.E fihletsoe ke tšebelisano-'moho ea AstraZeneca le Bristol-Myers Squibb Company 'me ke ea DPP-IV inhibitor.BMS-477118e bapala karolo ka ho thibela ho senyeha ha GLP-l.GLP-I ke lihomone tsa tlhaho tse hlahisoang ka maleng ka mor'a ho ja.E ka laola secretion ea insulin le ho matlafatsa ts'ebeliso ea tsoekere liseleng tsa peripheral.Moriana o le mong oa BMS-477118 o ka ntlafatsa taolo ea tsoekere ea mali le meriana e kopaneng ea BMS-477118 e nang le Metformin, Sulfonylurea le Thiazolidinediones e ka ntlafatsa phello ea pholiso.E lebisa kotsing e tlase ea hypoglycemia mme litlamorao tsa eona tse mpe li tšoana le placebo, e bonts'a mamello e betere.Ka la 31 Phupu 2009, BMS-477118 matlapa (Onglyza), sethethefatsi se secha sa lefu la tsoekere la mofuta oa 2, se entsoeng ka kopanelo le ho nts'etsapele AstraZeneca le Bristol-Myers Squibb e amohetsoe ke US FDA.E ka nkoa hang ka letsatsi ho phekola lefu la tsoekere la mofuta oa 2 hammoho le ho laola Lijo le boikoetliso.